261 related articles for article (PubMed ID: 3301391)
21. Reducing the risk of virus transmission by blood products.
Thomas DP
Br J Haematol; 1988 Dec; 70(4):393-5. PubMed ID: 3064802
[No Abstract] [Full Text] [Related]
22. Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses.
Hilfenhaus J; Gröner A; Nowak T; Weimer T
Transfusion; 1997 Sep; 37(9):935-40. PubMed ID: 9308641
[TBL] [Abstract][Full Text] [Related]
23. [Virus inactivation in blood products].
Stephan W
Beitr Infusionsther; 1988; 21():192-201. PubMed ID: 2462975
[No Abstract] [Full Text] [Related]
24. Safety of coagulation factor concentrates.
Teitel JM
Haemophilia; 1998 Jul; 4(4):393-401. PubMed ID: 9873760
[TBL] [Abstract][Full Text] [Related]
25. Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma.
Horowitz B; Lazo A; Grossberg H; Page G; Lippin A; Swan G
Vox Sang; 1998; 74 Suppl 1():203-6. PubMed ID: 9789529
[TBL] [Abstract][Full Text] [Related]
26. [Safety of transfusion therapy with special emphasis on inactivated viruses in products made from human blood].
Patko MS; Balija M; Grgicević D
Lijec Vjesn; 1995; 117(9-10):216-21. PubMed ID: 8643012
[TBL] [Abstract][Full Text] [Related]
27. Coagulation factor concentrates: past, present, and future.
Key NS; Negrier C
Lancet; 2007 Aug; 370(9585):439-48. PubMed ID: 17679021
[TBL] [Abstract][Full Text] [Related]
28. Evolving perspectives in product safety for haemophilia.
Farrugia A
Haemophilia; 2002 May; 8(3):236-43. PubMed ID: 12010417
[TBL] [Abstract][Full Text] [Related]
29. Factor IX concentrates: the new products and their properties.
Smith KJ
Transfus Med Rev; 1992 Apr; 6(2):124-36. PubMed ID: 1591489
[No Abstract] [Full Text] [Related]
30. Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
Stephan W
Curr Stud Hematol Blood Transfus; 1989; (56):122-7. PubMed ID: 2642784
[TBL] [Abstract][Full Text] [Related]
31. Strategies to produce virus-safe blood derivatives.
Heimburger N; Karges HE
Curr Stud Hematol Blood Transfus; 1989; (56):23-33. PubMed ID: 2910651
[No Abstract] [Full Text] [Related]
32. Safety of human albumin as a constituent of biologic therapeutic products.
McClelland DB
Transfusion; 1998 Jul; 38(7):690-9. PubMed ID: 9683109
[No Abstract] [Full Text] [Related]
33. Pasteurization as an efficient method to inactivate blood borne viruses in factor VIII concentrates.
Hilfenhaus J; Weidmann E
Arzneimittelforschung; 1986 Apr; 36(4):621-5. PubMed ID: 3013213
[TBL] [Abstract][Full Text] [Related]
34. The viral safety of intravenous immunoglobulin.
Cuthbertson B; Perry RJ; Foster PR; Reid KG; Crawford RJ; Yap PL
J Infect; 1987 Sep; 15(2):125-33. PubMed ID: 3117893
[TBL] [Abstract][Full Text] [Related]
35. The significance of the blood-borne viruses: blood banking and transfusion medicine.
Sherwood WC
Dev Biol Stand; 1993; 81():25-33. PubMed ID: 8174810
[TBL] [Abstract][Full Text] [Related]
36. Contamination of coagulation factor concentrates with human parvovirus B19 genotype 1 and 2.
Schneider B; Becker M; Brackmann HH; Eis-Hübinger AM
Thromb Haemost; 2004 Oct; 92(4):838-45. PubMed ID: 15467916
[TBL] [Abstract][Full Text] [Related]
37. [Viruses and unconventional transmissible agents: update on transmission via blood ].
Barin F
Transfus Clin Biol; 2000 Jun; 7 Suppl 1():5s-10s. PubMed ID: 10919217
[TBL] [Abstract][Full Text] [Related]
38. Viral safety and clotting factor concentrates.
Laurian Y; Lusher JM; Kessler CM
Thromb Haemost; 1994 Oct; 72(4):649. PubMed ID: 7878650
[No Abstract] [Full Text] [Related]
39. Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids.
Horowitz B; Piët MP; Prince AM; Edwards CA; Lippin A; Walakovits LA
Vox Sang; 1988; 54(1):14-20. PubMed ID: 2831669
[TBL] [Abstract][Full Text] [Related]
40. Current safety of clotting factor concentrates.
Epstein JS; Fricke WA
Arch Pathol Lab Med; 1990 Mar; 114(3):335-40. PubMed ID: 2407224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
